• FirefoxInstall the new Firefox »
  •  Dow Down 0.58% Nasdaq Down 0.26%

    More On CANF

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    Can-Fite BioPharma Ltd. (CANF)

    -NYSE MKT
    4.40 Down 0.10(2.22%) Mar 4, 4:01PM EST
    Add to Portfolio
    Prev Close:4.50
    Open:4.46
    Bid:4.42 x 100
    Ask:4.49 x 100
    1y Target Est:13.50
    Beta:3.55
    Next Earnings Date:N/A
    Day's Range:4.27 - 4.51
    52wk Range:2.29 - 6.24
    Volume:194,663
    Avg Vol (3m):212,853
    Market Cap:39.27M
    P/E (ttm):N/A
    EPS (ttm):-0.82
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CANF

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.31
    Quarterly EPS Est (Dec-14) :-0.08
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Can-Fite BioPharma, Ltd., a clinical-stage biotechnology company, develops small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological, and ophthalmic diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback